SMQ-17563-62718
3 vaccinations
5 coded responses
29 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 138 / NY
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Health check-in — day 0, dose 1Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: Pain · Muscle or body achesFree text: Last night the area I got my shot in (upper arm) was very warm to the touch.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Menstruation delayed — Feeling: GoodFree text: I have not gotten my period when I should after getting the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — day 7, dose 1MedDRA: Amenorrhoea, Menstrual disorder — Feeling: Good · Fatigue or tirednessFree text: Lack of menstrual period (supposed to have now, very light).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-20
- 2021-02-28
- 2021-03-05
- 2021-03-13
- 2021-04-30
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Intermenstrual bleeding, Weight increased — Feeling: GoodFree text: Continuous spotting after period. Weight gain.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-27
Dose 3 — Pfizer-BioNTech
- 2021-12-29
- 2021-12-30
- 2021-12-31
- 2022-01-02
-
2022-01-12
Survey response — day 14, dose 3MedDRA: Nasal congestion — Feeling: FairFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2022-01-17
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-12-27 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Last night the area I got my shot in (upper arm) was very warm to the touch.
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): I have not gotten my period when I should after getting the vaccine.
Release 2 — day 7, dose 1
Systemic reaction (other): Lack of menstrual period (supposed to have now, very light).
Release 9 — 6 months, dose 2
Symptoms: Continuous spotting after period. Weight gain.
Release 10 — day 14, dose 3
Symptoms: Stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Intermenstrual bleeding | ✓ | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Weight increased | ✓ | · | ✓ |
| SRO | Amenorrhoea | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Menstrual disorder | ✓ | ✓ | ✓ |
| SRO | Menstruation delayed | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release